MACROGENICS INC — Director's Dealing 2024

Feb 12, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MACROGENICS INC (MGNX)
CIK: 0001125345
Period of Report: 2024-02-08

Reporting Person: Spitznagel Thomas (Sr VP, Technical Ops)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-02-08	Employee Stock Option (right to buy)	$18.30	A	71000	Acquired	2034-02-08	Common Stock (71000)	Direct
2024-02-08	Restricted Stock Unit	$	A	27000	Acquired		Common Stock (27000)	Direct

Footnotes

F1: 12.5% of the shares underlying the grant became exercisable 6 months after the date of grant and an additional 6.25% of the shares underlying the grant became exercisable on the first day of each three-month period thereafter.

F2: Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's common stock.

F3: The RSUs will vest as to 33% of the total shares one year after the date of grant and 33% each year thereafter.